Conference proceedings · 2007 · 41 citations · 6 references
MedicineCancer BiologyOncologyComputational BiologyMedical OncologyTumor ProgressionComputational OncologyDisease Progression ModelingMalignant NeoplasmsTherapy Response AssessmentTumor BiologyTumor Growth KineticsCancer Drug Response ModelingMulti-scale Cancer ModelingPersonalized Cancer TreatmentTreatment OptimisationTumor Growth DynamicsTumor Growth Inhibition ModelingTumor Growth RateTumor Response Prediction
The "Oncosimulator" is at the same time a concept of multilevel integrative cancer and (treatment affected) normal tissue biology, an algorithmic construct and a software tool which aims at supporting the clinician in the process of optimizing cancer treatment on the patient individualized basis. Additionally it is a platform for better understanding and exploring the natural phenomenon of cancer as well as training doctors and interested patients alike. In order to achieve all of these goals it has to undergo a thorough clinical optimization and validation process. This is one of the goals of the European Commission funded integrated project "ACGT: Advancing Clinicogenomic Trials on Cancer". Nephroblastoma (Wilms' tumor) and breast cancer have been selected to serve as two paradigms to clinically specify and evaluate the "Oncosimulator" as well as the emerging domain of in silico oncology.
6
Dimitra D. Dionysiou, Georgios Stamatakos, N.K. Uzunoglu et al. · Journal of Theoretical Biology · 2004 · 108 citations · Full text
Target genes of the WNT/β‐catenin pathway in Wilms tumors
Birgit Zirn, Birgit Samans, Stefanie Wittmann et al. · Genes Chromosomes and Cancer · 2006 · 82 citations
Georgios Stamatakos, V.P. Antipas, N.K. Uzunoglu · IEEE Transactions on Biomedical Engineering · 2006 · 59 citations · Full text
Medicine, Oncology, Pharmacology +17